(Q37842130)

24 August 2017

1 reference

title

Novel biomarkers for overactive bladder (English)

1 reference

24 August 2017

0 references

Rufus Cartwright

1

1 reference

24 August 2017

Iram Afshan

2

1 reference

24 August 2017

Alexandros Derpapas

3

1 reference

24 August 2017

Gopalan Vijaya

4

1 reference

24 August 2017

Vik Khullar

5

1 reference

24 August 2017

language of work or name

English

0 references

publication date

15 February 2011

1 reference

24 August 2017

published in

Nature Reviews Urology

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

139-145

1 reference

Is the prevalence of overactive bladder overestimated? A population-based study in Finland

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Prevalence of the overactive bladder syndrome by applying the International Continence Society definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Incidence and remission of female urinary incontinence over 6.5 years: analysis of a health screening project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

The clinical significance of the urodynamic investigation in incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Overactive bladder: a clinical entity or a marketing hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Lower urinary tract symptomatology: Its definition and confusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Persistence of antimuscarinic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Role of cystometry in evaluating patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Cystometrical sensory data from a normal population: comparison of two groups of young healthy volunteers examined with 5 years interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Can a faked cystometry deceive patients in their perception of filling sensations? A study on the reliability of spontaneously reported cystometric filling sensations in patients with non-neurogenic lower urinary tract dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Observations relating to urinary sensation during detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Quality control in urodynamics: Analysis of an international multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Overactive bladder symptoms: do we need urodynamics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Predictive value of urodynamics on outcome after midurethral sling surgery for female stress urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

The inadequacy of urinary dipstick and microscopy as surrogate markers of urinary tract infection in urological outpatients with lower urinary tract symptoms without acute frequency and dysuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Interactions of calcium, prostaglandins and indomethacin on the smooth muscle of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. A urodynamic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Prostaglandin E2 release from isolated bladder strips in rats with spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Long-lasting breaches in the bladder epithelium lead to storage dysfunction with increase in bladder PGE2 levels in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

A higher level of prostaglandin E2 in the urinary bladder in young boys and boys with lower urinary tract obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Sensitisation of visceral afferents by nerve growth factor in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Neurally mediated hyperactive voiding in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urethral mobility and urinary incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Transvaginal ultrasound measurement of bladder wall thickness: a more reliable approach than transperineal and transabdominal approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Systematic review of the accuracy of ultrasound as the method of measuring bladder wall thickness in the diagnosis of detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Ultrasound Estimated Bladder Weight and Measurement of Bladder Wall Thickness—Useful Noninvasive Methods for Assessing the Lower Urinary Tract?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

International Consultation on Incontinence-Research Society (ICI-RS) report on non-invasive urodynamics: the need of standardization of ultrasound bladder and detrusor wall thickness measurements to quantify bladder wall hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Brain control of normal and overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Central nervous system findings on functional magnetic resonance imaging in patients before and after treatment with anticholinergic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Familial risk of urinary incontinence in women: population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Genetic influence on stress urinary incontinence and pelvic organ prolapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Does monosymptomatic enuresis exist? A molecular genetic exploration of 32 families with enuresis/incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Beta3-adrenoceptors in urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Beta-adrenoceptor polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first‐pass metabolism, CYP2D6 genotype and formulation‐dependent bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

The clinical pharmacokinetics of darifenacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Effect of tolterodine on sleep structure modulated by CYP2D6 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

QT and QTc interval with standard and supratherapeutic doses of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Genetics and the lower urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Peripheral blood mononuclear cell gene array profiles in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Overactive bladder and the definition of urgency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Changes in bladder volumes with repetition of water cystometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

How reliable are bladder perceptions during cystometry?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Short- and long-term reproducibility of cystometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Is catheter cause of subjectivity in sensations perceived during filling cystometry?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

How sudden is a compelling desire to void? An observational cystometric study on the suddenness of this sensation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Reliability testing of urodynamics, pressure flow studies and cough leak point pressure in women with urodynamic stress incontinence with and without detrusor overactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Predictors of outcomes in the treatment of urge urinary incontinence in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Utility of urine reagent strip in screening women with incontinence for urinary tract infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Prostaglandin type E activity dominates in urinary tract smooth muscle in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urinary nerve growth factor in women with overactive bladder syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Spinning top urethra: not a normal variant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

The reliability of cysto-urethrographic signs in the diagnosis of detrusor instability in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Three-dimensional ultrasound of the urethral sphincter predicts continence surgery outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Bladder wall thickness on ultrasonographic cystourethrography: affecting factors and their implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Ultrasound measurement of bladder wall thickness in different forms of detrusor overactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Sonographic transvaginal bladder wall thickness: Does the measurement discriminate between urodynamic diagnoses?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Ultrasound assessment of detrusor muscle thickness in children with non-neuropathic bladder/sphincter dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Discrimination of bladder disorders in female lower urinary tract symptoms on ultrasonographic cystourethrography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Is ultrasound estimation of bladder weight a useful tool in the assessment of patients with lower urinary tract symptoms?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Urinary incontinence in nulliparous women and their parous sisters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Genetic and environmental influences on urinary incontinence: a Danish population-based twin study of middle-aged and elderly women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.7

Linkage study of a large Danish 4-generation family with urge incontinence and nocturnal enuresis

31 March 2020

1 reference

12 December 2020

Imaging the urethral sphincter with three-dimensional ultrasound

1 reference

12 December 2020

Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence

1 reference

12 December 2020

Standardized ultrasound method for assessing detrusor muscle thickness in children.

1 reference

12 December 2020

An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction

1 reference

12 December 2020

Terodiline treatment of detrusor hyperreflexia in sclerosis multiplex

1 reference

12 December 2020

Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women

1 reference

12 December 2020

Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins?

1 reference

12 December 2020

The significance of ultrasonography in diagnosing and follow-up of cystic cystitis in children

1 reference

12 December 2020

A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey

1 reference

12 December 2020

Quest for a detrusor overactivity index

1 reference

12 December 2020

Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2011.7

1 reference

24 August 2017

1 reference